Breast cancer (BC) is characterized by an extensive genotypic and phenotypic
heterogeneity. In-depth investigations into the molecular bases of BC phenotypes …

Breast cancer is a global health concern with a significant impact on the well-being of
women. Worldwide, the past several decades have witnessed changes in the incidence and …

Breast cancer prognosis and management for both men and women are reliant upon
estrogen receptor alpha (ERα) and progesterone receptor (PR) expression to inform …

Tumor suppressor p53 can transcriptionally activate downstream genes in response to
stress, and then regulate the cell cycle, DNA repair, metabolism, angiogenesis, apoptosis …

Breast cancer (BC) is the most common non-skin cancer and the second leading cause of
cancer death in American women. The initiation and progression of BC can proceed through …

Background The murine double minute 2 (MDM2) gene is a crucial factor in the
development and progression of various cancer types. Multiple rigorous scientific studies …

Precision oncology is based on deep knowledge of the molecular profile of tumors, allowing
for more accurate and personalized therapy for specific groups of patients who are different …

Simple Summary In the evolving landscape of breast cancer care, recognizing HER2-low
expression as a target for anti-HER2 therapies has revolutionized treatment approaches …

Aggressive triple-negative breast cancer (TNBC) is a current threat worldwide. The
ineffectiveness of current TNBC therapy options highlights the need for innovative …

Breast cancer is one of the top two reproductive cancers responsible for high rates of
morbidity and mortality among women globally. Despite the advancements in the treatment …